Inflammatory biomarkers in Alzheimer's disease plasma.

• Morgan AR Systems Immunity Research Institute and UK Dementia Research Institute Cardiff, School of Medicine, Cardiff University, Cardiff, UK.
• Touchard S Systems Immunity Research Institute and UK Dementia Research Institute Cardiff, School of Medicine, Cardiff University, Cardiff, UK.
• Leckey C Systems Immunity Research Institute and UK Dementia Research Institute Cardiff, School of Medicine, Cardiff University, Cardiff, UK.
• O'Hagan C Systems Immunity Research Institute and UK Dementia Research Institute Cardiff, School of Medicine, Cardiff University, Cardiff, UK.
• Nevado-Holgado AJ Department of Psychiatry, University of Oxford, Oxford, UK.
• Barkhof F Max Planck Institute for Molecular Genetics, Berlin, Germany.
• Bertram L Aix-Marseille University, APHM, Institute Neurosci System, Pharmacology, Marseille, France.
• Blin O Alzheimer Centrum Limburg, Maastricht University, Maastricht, the Netherlands.
• Bos I Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lübeck, Germany.
• Dobricic V Department of Neurology, Hospital Network Antwerp (ZNA), Antwerp, Belgium; Reference Center for Biological Markers of Dementia, Institute Born-Bunge, Antwerp, Belgium.
• Engelborghs S University of Geneva, Geneva, Switzerland; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
• Frisoni G Department of Geriatric Psychiatry, Zentralinstitut für Seelische Gesundheit, University of Heidelberg, Mannheim, Germany.
• Frölich L Department of Neurosciences, Laboratory for Cognitive Neurology, KU Leuven, Leuven, Belgium.
• Gabel S Division of Clinical Geriatrics, Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
• Johannsen P University of Gothenburg, Institute of Neuroscience and Physiology, Gothenburg, Sweden.
• Kettunen P Department of Old Age Psychiatry & Psychotic Disorders, Medical University of Lodz, Lodz, Poland.
• Kłoszewska I UCL Institutes of Neurology and Healthcare Engineering, University College London, London, UK; School of Public Health, Imperial College London, London, UK.
• Legido-Quigley C Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
• Lleó A CITA-Alzheimer Foundation, San Sebastian, Spain.
• Martinez-Lage P Department of Medicine, Institute of Gerontology and Geriatrics, University of Perugia, Perugia, Italy.
• Mecocci P Department of Neurosciences, Laboratory for Cognitive Neurology, KU Leuven, Leuven, Belgium.
• Meersmans K Barcelona Beta Brain Research Center, Unversitat Pompeu Fabra, Barcelona, Spain.
• Molinuevo JL Department of Psychiatry, Old Age Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.
• Peyratout G Hopitaux Universitaires Geneve and Universite de Geneve, Geneva, Switzerland.
• Popp J Neurosciences Therapeutic Area, GlaxoSmithKline R&D, Stevenage, UK.
• Richardson J Memory Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
• Sala I Alzheimer Center, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, the Netherlands.
• Scheltens P Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
• Streffer J Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland.
• Soininen H Center for Research and Advanced Therapies. CITA-Alzheimer Foundation, San Sebastian, Spain.
• Tainta-Cuezva M University Hospital Leuven, Leuven, Belgium.
• Teunissen C 1st Department of Neurology, AHEPA University Hospital, Makedonia, Thessaloniki, Greece.
• Tsolaki M Department of Clinical Chemistry, Neurochemistry lab, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
• Vandenberghe R Department of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
• Visser PJ Alzheimer Centrum Limburg, Maastricht University, Maastricht, the Netherlands.
• Vos S NVS-Department, Section of Clinical Geriatrics, Karolinska Institutet, Huddinge, Sweden.
• Wahlund LO Section for Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg Sahlgrenska Academy, Gothenburg, Sweden.
• Wallin A Department of Psychiatry, University of Oxford, Oxford, UK.
• Westwood S Clinical Neurochemistry Lab, Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, Mölndal, Sweden; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; UK Dementia Research Institute, London, UK.
• Zetterberg H Department of Psychiatry, University of Oxford, Oxford, UK.
• Lovestone S Systems Immunity Research Institute and UK Dementia Research Institute Cardiff, School of Medicine, Cardiff University, Cardiff, UK. Electronic address: morganbp@cardiff.ac.uk.
• Morgan BP

Show more…

Alzheimer's disease

Biomarker

Complement

Inflammation

Plasma

Aged

Alzheimer Disease

Amyloid beta-Peptides

Biomarkers

Cognitive Dysfunction

Cohort Studies

Complement Factor B

Complement Factor H

Humans

Inflammation

Internationality

Prognosis